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Abstract 
The underlying processes by which gene expression is regulated is crucial to 
understanding the onset and progression of many diseases, most notably cancer. RNA 
Polymerase II transcribes the mRNAs destined to make proteins, but there is an 
abundance of protein factors which regulate, recruit, inhibit and control Pol II to achieve 
tight control over which genes are expressed and when. This thesis focuses on two 
families of transcriptional activators: the NFAT family, and the AP-1 family. Both 
families of transcriptional activators have been found to have a role in the onset and 
growth of cancers, but the mechanisms remain unclear. 
First, the role of NFATc2 in the cellular response to environmental carcinogens is 
examined. It is found that cadmium exposure induces calcium oscillations in a breast 
cancer cell line. This, combined with data from gene reporters and endogenous gene 
expression, leads to a hypothesis that cadmium may activate NFATc2-controlled 
transcriptional programs. 
Second, the development of two tools which probe different aspects of transcriptional 
regulation is presented. The first tool, NFATc2-APEX2, uses specially restricted 
promiscuous labeling to detect proteins which associate with NFATc2. If successful, 
APEX2-labeling has the potential to detect previously unidentifiable protein interactions. 
Finally, this thesis discusses the characterization of a DNA aptamer selected to bind 
cJun/cJun homodimers selectively and with high affinity, a second tool for understanding 
transcriptional regulation. The binding affinity of the aptamer for the cJun/cJun 
homodimer has been determined, along with the aptamer secondary structure, the 
aptamer interaction regions, and the minimal domain required for high-affinity binding.  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Chapter 1: An Introduction to Transcription and Transcriptional Regulation in Eukaryotes 
Transcriptional regulation can be thought of as a problem in information transfer: There are 
approximately 20,000 protein-coding genes contained within the human genome, but only a 
small fraction of these are expressed in any given cell1. Contained within this genome are the 
instructions to make neurons, bone cells, skin cells and any other type of tissue a human needs. 
But neurons don’t need to be able to produce the hydroxyapatite required for bone production, 
and osteoblasts have no need for the proteins that produce gastric juices. As such, intermediary 
steps that allow a cell to produce one set of genes over another are vitally important to a 
successful organism. An understanding of how the information encoded in the genome is 
expressed in a regulated manner is crucial in designing and improving current treatments for a 
wide variety of diseases. 
RNA Polymerase II and the general transcription factors 
Transcription, the process by which RNA is synthesized from a DNA template, is an 
absolutely essential biological process which is conserved in all known domains of life2. This 
process occurs through the successive incorporation of nucleotide triphosphates (NTPs) 
catalyzed by the active site of an RNA polymerase, and is energetically driven by the release and 
rapid degradation of pyrophosphate as each nucleotide is incorporated into the nascent RNA 
strand3. A high degree of message fidelity is achieved through hydrogen bonding interactions 
between the template strand of the DNA and the incoming NTP, coupled with efficient 
proofreading4,5. 
RNA Polymerase II (Pol II) is one of three RNA polymerases in eukaryotic organisms. Its 
function is to transcribe messenger RNA (mRNA) from protein coding sequences in the genome, 
as well as to transcribe certain snRNAs, mircoRNAs, and newly identified classes of long non-
coding RNAs1. Pol II consists of twelve distinct protein subunits (RPB1 through RPB12). 
Together they comprise distinct structural regions that include: (1) the active site for DNA-
templated RNA synthesis, (2) a clamp to keep the DNA in the active site, (3) a funnel through 
which incoming NTPs can enter the enzyme active site, and (4) a “rudder” which splits apart the 
growing RNA strand from the DNA template1,6. The carboxyl terminal domain of RPB1 is 
composed of up to 52 heptad repeats (YSPTSPS), which are heavily post-translationally 
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modified, and which are required for the successful production and processing of a mature 
mRNA7, 8. 
Although Pol II itself can catalyze the synthesis of RNA transcripts, early experiments 
showed that it lacks specificity for promoter regions, and cannot itself initiate RNA synthesis at a 
precise location. To do so, it requires a set of nuclear proteins now known as the general 
transcription factors (GTFs; TFIIA, TFIIB, TFIID, TFIIE, TFIIF, TFIIH). These factors contain a 
host of activities such as promoter-specific binding and helicase activity which assist in the 
formation of a stable pre-initiation complex (PIC), DNA melting, and productive transcription 
initiation2,9. 
PIC assembly begins with the association of TFIID, a massive multi-protein complex 
consisting of TATA-binding protein (TBP) as well as the TBP Associated Factors (TAFs) (Figure 
1.1)5,10. Assisted by TFIIA, TFIID binds to and bends the DNA via the TBP subunit, which 
recognizes the TATA-box, an element of the core promoter ~30 nucleotides upstream of the 
transcription start site11. The TAF subunits of TFIID also associate with promoter elements 
downstream of the TATA box. It is thought that the bent DNA facilitates the association of Pol II 
and other GTFs including TFIIB, TFIIE, TFIIF, and TFIIH12. Upon binding, the helicase activity 
of TFIIH hydrolyzes ATP in order to melt a bubble in the DNA, exposing the template strand13,14. 
With the template exposed, Pol II can initiate transcription, but often multiple short abortive 
products are produced before the polymerase can escape the promoter to transition from an 
initiation complex into an elongation complex. Once promoter escape occurs, most of the GTFs 
will dissociate from Pol II and the promoter region, with the exception of TFIIF–which remains 
associated with Pol II throughout elongation–and TFIID, which remains at the promoter and 
undergoes another round of PIC assembly12,15. 
Promoter architecture and the regulation of transcription in mammals 
The architecture of a eukaryotic promoter consists of a number of cis-acting elements which 
fall into the broad categories of either the core promoter, proximal regulatory elements, or 
enhancers15. The core promoter contains the TATA-box, the transcription start site, and a 
downstream promoter element, allowing for the association of Pol II and the GTFs12. The 
proximal regulatory elements flank the core promoter for a few hundred base pairs in either  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Figure 1.1: A general schematic for the assembly of the PIC. The TATA box, 34 base pairs upstream of the 
transcription start site (red arrow) is bound by TBP, which is in turn bound to the TAFs and other factors that 
comprise TFIID (not shown). TFIIA associates and stabilizes the complex. Pol II and TFIIF are recruited to the 
transcription start site, followed by TFIIE and TFIIF, which melts the DNA to expose the template strand.
direction, and contain recognition elements to which transcription factors (e.g. activators and 
repressors) may bind. Proximal regulatory elements are often characterized by a high degree of 
dependance on distance from the core promoter. Enhancers, and other distant regulatory 
elements, also allow for the binding of transcription factors, but in contrast with the proximal 
regulatory elements, they are often thousands or tens of thousands of bases away from the core 
promoter. Enhancers are thought to function by looping out the intervening DNA to allow 
enhancer-bound transcription factors to interact with factors bound to proximal regulatory 
elements and the core promoter. As such these enhancer sequences can be functional even when 
moved to different locations on the chromosome16. 
Transcription factors are proteins that bind to specific DNA sequences in order to regulate the 
expression of a given gene17. This generic term encompasses any factor which binds DNA to 
regulate gene expression, despite many different functions and mechanisms of action. Some 
transcription factors aid in the recruitment and assembly of the general transcription machinery, 
whereas others may interact with the PIC to change expression levels. Often, transcription 
factors bound to enhancer elements alter transcription levels through interactions with bridging 
protein cofactors that don’t bind DNA directly; for example, the massive protein complex 
Mediator (Figure 1.2)18, 19. 
Transcriptional activators are combinatorial in nature: multiple activators work together in 
highly specific combinations to control transcription of individual genes. For example, 
transcriptional activators A and B may regulate a distinct set of genes compared to transcriptional 
activators A and C20. This combinatorial nature extends to far more than two transcription factors 
at any particular gene, and many factors are context and cell-type dependent, contributing to the 
complexity of understanding transcriptional regulation21. 
Transcription is also regulated by modulating the accessibility of promoter DNA to Pol II and 
the GTFs22. The higher order compaction of DNA begins by winding the DNA around histone 
octamers comprised of two copies each of H2A, H2B, H3 and H423. Regions of DNA in the 
transcriptionally active euchromatin state contain histones with specific post-translational 
modifications (e.g. methylation and acetylation) on their tails that facilitate recruitment of Pol II 
and the GTFs to the core promoter24. Regions of the DNA in the heterochromatin state are  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Figure 1.2: The architecture of a mammalian promoter. RNA Polymerase II and the GTFs bind 
elements that make up the core promoter, present at all genes. The proximal promoter 
elements can be found within a few hundred bases of the core promoter, and contain 
recognition sequences for transcription factor binding. Enhancer elements can be found 
thousands to hundreds of thousands of bases away from the transcription start site, and often 
tune transcription levels by interacting with protein coactivators and/or mediator.
characterized by repressive histone modifications, inhibiting transcription by preventing Pol II 
and other proteins access to the necessary elements to initiate transcription. Post translational 
modifications to the amino-terminal region of histones allow the association of specific protein 
factors to facilitate these regulatory processes25, 26. 
The AP-1 Family of transcriptional activators 
The Activator Protein 1 (AP-1) family of proteins is a large family characterized by their 
basic leucine zipper (bZip) domain, so named for the five leucine repeats evenly spaced along an  
α-helix, which allow for dimerization through hydrophobic and electrostatic interactions27 
(Figure 1.3). The act of dimerization in AP-1 proteins is cooperative with DNA binding, such 
that the binding of DNA induces the formation of the coiled coil of α-helices (Figure 1.3), and 
greatly increases the binding affinity of each subunit for the other in the dimer pair. All AP-1 
dimers contain a DNA binding domain that recognizes the same consensus TPA responsive 
element (TRE, consensus 5’-TGA(C/G)TCA-3’), but the specific components of the dimer pair 
alters the activity and specificity of the dimer for regulating promoter-specific transcription28. A 
challenge shared when studying AP-1 proteins, or other transcriptional activators, is the dynamic 
nature of their activation domains that makes them highly resistant to crystallization or structure 
determination by NMR. This makes even more difficult the understanding of exactly how these 
different dimer combinations achieve this specificity. 
The AP-1 family can be subdivided into members of the Jun, Fos, ATF and MAF subfamilies, 
each with specific characteristics. Jun proteins have the ability to form homodimers and to 
dimerize with other Jun family members, in addition to their ability to form heterodimers with 
Fos family proteins. Fos proteins, on the other hand, cannot homodimerize, and instead can only 
heterodimerize complexes with Jun, ATF, or MAF proteins29. AP-1 proteins are induced by a 
variety of extra- and intracellular factors such as the tumor inducer  
12-O-tetradecanoylphorbol-13-acetate (TPA) as well as external growth factors and cytokines 
which activate the mitogen-activated protein kinase (MAPK) signaling cascade. These signals 
are integrated primarily by Jun N-terminal kinase (JNK), p38, and extracellular signal regulated 
kinase (ERK). They act by phosphorylating AP-1 proteins, thereby altering the proteins’ stability, 
specificity, and activity30, 31. 
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Figure 1.3: The structure of AP-1 proteins. A crystal structure of the basic leucine zipper 
region of a cFos (red) and cJun (blue) dimer. The leucine repeats (orange) can be clearly seen 
interacting with each other as the DNA binding domain binds the canonical sequence 5’-
TGA(G/C)TCA-3’. Glover, J. N., and Harrison, S. C. Crystal structure of the heterodimeric bZIP transcription 
factor cFos-cJun bound to DNA, Nature 373, 257-261 (1995).
AP-1 proteins help to govern a vast array of different cellular processes, many involved with 
cell cycle regulation, growth, and differentiation. The family has long been known to have a role 
in tumorigenesis, but more recently it has been shown that certain AP-1 family members may act 
as tumor suppressors29. Understanding the exact role of any one dimer pair remains a limiting 
factor in the ability to target AP-1 proteins for therapeutic research. 
The NFAT family of transcriptional activators 
Proteins in the nuclear factor of activated T cells (NFAT) family were first characterized for 
their role in T cell differentiation during an immune response32. Under normal conditions, NFAT 
proteins remain excluded from the nucleus and in a hyper-phosphorylated state. Efflux of 
calcium from the endoplasmic reticulum causes activation of calmodulin (a calcium binding 
protein) and calcineurin (a phosphatase). Activated calcineurin dephosphoyrlates key residues on 
NFAT, which exposes a nuclear localization signal and allows NFAT translocation into the 
nucleus33. This process is reversible by active kinases within the nucleus, such as casein kinase I 
or dual specificity tyrosine phosphorylation regulated kinase 2. These kinases work to re-
phosphorylate NFAT proteins, causing export of NFAT back out into the cytosol34. 
There are five members of the NFAT family, each of which has multiple alternative splicing 
variants. The best characterized of these are the proteins NFATc1 and NFATc2. Though 
structurally distinct, NFATc1 and NFATc2 contain two conserved regions common to their 
function35 (Figure 1.4A). The NFAT homology region (NHR) contains phosphorylation sensitive 
docking sites for calcineurin, as well as the nuclear localization signal for NFAT trafficking. The 
Rel-like domain contributes to the specificity for DNA binding34,35.  
NFAT proteins also have been found to play a role in cancer development. Biopsies of 
invasive human carcinomas show a significant increase in NFATc1 and NFATc2 expression36. 
These transcriptional activators drive expression of factors such as Cox237 and autotaxin34, both 
of which increase cell motility and drive cell invasion. Even still, the mechanisms by which 
NFAT interacts with other transcription factors in promoting cancer proliferation and invasion 
remains unclear. 
!
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Figure 1.4: The structure of NFAT proteins. A) NFATc2 and NFATc1 have two homologous 
domains: the NFAT Homology region (NHR) that contains the docking site for calcineurin, and 
the Rel-like domain involved in DNA binding. B) A crystal structure of the DNA binding domains 
of AP-1 and NFAT1 (NFATc2), showing how the proteins can form a stable ternary complex 
when bound to DNA. Macián, F., López-Rodríguez, C. & Rao, a. Partners in transcription: NFAT and AP-1. 
Oncogene 20, 2476–89 (2001).
A)
B)
NFAT and AP-1 proteins cooperate to activate transcription 
No transcription factor works alone to drive gene expression, but instead works in concert 
with hosts of other transcription factors, producing the complex control over cell fate that we 
observe. During T cell development, the co-stimulation of NFAT and AP-1 proteins leads to 
cooperative binding at the promoter of the IL-2 (interleukin-2) gene, which encodes an essential 
cytokine for the mammalian immune response38. NFATc2 and AP-1 proteins form stable ternary 
complexes with promoter DNA through interactions between the bZip domain of the AP-1 
proteins and Rel-homology domain of NFAT39 (Figure 1.4B). 
The work of this thesis is motivated by two considerations: First, that both AP-1 family 
proteins (and in particular cJun) and NFAT proteins have been shown to have roles in promoting 
growth, invasion, and angiogenesis in cancerous cells. Second, that the interactions between 
these two proteins function in a highly cooperative manner to drive gene expression in the 
immune response. Consequently, we are interested in determining whether similar interactions 
might govern the fate of cells in breast cancer. 
The work outlined in this thesis focuses on the investigation of NFAT and AP-1 proteins, and 
discovering better tools to monitor their activity. Chapter 2 presents an ongoing project whose 
aim is to determine whether known environmental carcinogens drive transcriptional programs 
controlled by cJun and NFATc2. Chapters 3 and 4 present the development of two tools: one that 
may be useful in determining what other protein factors work with NFAT to regulate gene 
expression, and one that can distinguish cJun/cJun homodimers from cJun/cFos heterodimers. It 
is hoped that this work will result in a better understanding of the mechanisms by which these 
transcription factors contribute to cancer development and growth.  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Chapter 2: Investigating cellular calcium levels, NFAT translocation, and transcript levels 
in response to environmental carcinogens 
Introduction 
As the incidence of cancers continue to increase—particularly in the Western world—an 
understanding of the interplay between environmental factors and human health has become 
more critical to the understanding, diagnosis and treatment of the disease40. Cancer is an 
umbrella term for the atypical division of cells leading to the formation of tumors. It is an 
incredibly heterogenous disease which can afflict nearly all tissue types, and can have numerous 
different causes including genome instability and catastrophic DNA damage. The result is a cell 
or tissue that fails to express the normal safeguards preventing cells from overgrowing their 
environment41. Environmental factors can initiate or exacerbate these effects by altering the 
normal transcriptional program in the cell, potentially contributing to the proliferation or 
invasiveness of the cancerous tissue42. Two well established groups of environmental factors that 
promote tumor growth or invasion are polycyclic aromatic hydrocarbons (PAHs) and heavy 
metals43, 44. 
PAHs are a broad class of organic compounds characterized by highly conjugated systems of 
aromatic rings. They are the byproducts of numerous production and refining processes such as 
crude oil refinement, coke oven emissions, motor vehicle emissions, and tobacco smoke45. They 
are metabolized by cytochrome enzymes, such as those involved in oxidative phosphorylation. 
Metabolism of PAHs, in particular benzo[a]pyrene (B[a]P), forms highly reactive epoxides 
which can interact covalently with DNA, permanently damaging it. In addition, B[a]P can be 
metabolized to a quinone which can interfere with the Q cycle and other cellular processes45. 
Heavy metals are another broad class of environmental carcinogens, often appearing in sites 
where mining and mineral enrichment are prevalent. A notable issue with many heavy metal 
carcinogens is their tendency to accumulate in tissues, and hence their levels increase as one 
moves up the food chain. Divalent heavy metals such as cadmium, chromium(VI), nickel(II), 
cobalt(II), and mercury have all been shown to induce carcinomas in animal studies46. One 
hypothesis suggests that these divalent cations mimic free Ca2+ to misregulate signaling 
pathways activated by calcium, but exact mechanisms have not been elucidated47. 
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With both PAHs and heavy metals, the sequence of events from carcinogen exposure to the 
formation of a cancerous tumor is unclear. However, studies have shown that both B[a]P and 
cadmium increase levels of free calcium in the cytosol42-44, 48. Given the mechanism by which the 
NFAT family of transcriptional activators are activated in a calcium dependent manner, this led 
us to wonder if exposure to these environmental carcinogens was initiating the transcriptional 
programs driven by NFAT. Additionally, recent studies have found that exposure to cadmium 
activates the MAPK signal cascade and has been shown to increase cJun expression in human 
prostate cells46, 49. Together, these led us to wonder whether NFAT was cooperating with cJun to 
mediate transcriptional activation in this capacity. 
Presented here are the results of experiments monitoring calcium levels, NFAT localization, 
and transcript levels after breast cancer cells were treated with cadmium and B[a]P. We used a 
genetically encoded calcium sensor to evaluate the previously published data supporting an 
increase in cytosolic calcium upon treatment with cadmium and B[a]P. We then characterized the 
activity of a fusion protein that allows us to follow the translocation of NFATc2 from the 
cytoplasm to the nucleus in real time. Finally, we examine the endogenous expression levels of 
mRNAs thought to be activated by NFAT to phenotypically characterize the effect of these 
carcinogens. 
Results 
Genetically encoded calcium sensors do not show an increase in cytosolic calcium 
We wanted to see if exposure to either B[a]P or cadmium would induce an increase in 
cytosolic calcium. To this end, we used D3cpV–a genetically encoded calcium sensor consisting 
of calmodulin flanked by cyan fluorescent protein (CFP) on one end, and yellow fluorescent 
protein (YFP) on the other50, 51. Because of their close proximity, excitation of the CFP can cause 
fluorescence resonance energy transfer (FRET), transferring energy from the CFP to the YFP and 
resulting in a photon emission from the YFP in a distance-dependent manner. Upon binding 
calcium, there is a conformational change in the calmodulin domain, bringing the two 
fluorescent proteins closer together and changing the FRET between the two. These changes in 
FRET can be expressed as the ratio of the intensity of the YFP FRET emission to CFP emission. 
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D3cpV was expressed in the mammary gland adenocarcinoma cell line MDA-MB-231.  To 
test the FRET-based calcium sensor, initial experiments treated cells with ionomycin, an 
ionophore which floods the cytosol with calcium from the ER52. When ionomycin was added to 
cells in a calcium-free buffer in the presence of a chelator such as EGTA, there was a sharp spike 
in FRET followed by a return to the basal FRET state, corresponding to a release of calcium 
from the ER followed by sequestration of the free calcium by EGTA (Figure 2.1A). The buffer 
was changed to a calcium-rich buffer, and the cells were allowed to recover for approximately 3 
minutes. When they were then treated with ionomycin alone, we observed a sustained 3-fold 
increase in the YFP/CFP FRET ratio. This confirms that the D3cpV reporter is successfully 
responding to changes in intracellular calcium. 
To address whether treatment with carcinogens would lead to an increase in free cytosolic 
calcium, we treated cells with either cadmium or B[a]P in phenol-free growth medium and 
imaged them at 2 minute intervals over a 12-hour time course. Contrary to expectation, and to 
what has previously been reported in the literature, neither B[a]P nor cadmium exposure resulted 
in a sustained increase in free calcium. Instead, FRET ratios remained relatively constant across 
the time course (Figure 2.1B, C). 
Cadmium-treated cells experience calcium oscillations 
During the optimization of the imaging conditions an intriguing result was observed. MDA-
MB-231 cells treated with cadmium experienced relatively regular calcium oscillations. To 
explore this further, we transfected cells with D3cpV and imaged them at 15 second intervals 
after cadmium treatment. Not all cells experienced these regular oscillations, and the magnitude 
of the changes varied from cell to cell, but the majority of cells showed calcium oscillations with 
a period of approximately 4.5 minutes. Neither untreated cells, nor cells treated with B[a]P 
experience these oscillations (data not shown). Furthermore, cadmum-induced oscillations 
extended for almost 2 hours after treatment (Figure 2.2). 
mApple-NFATc2 is functional and transcriptionally active 
Intrigued by the possibility that the calcium oscillations we observed could be a means of 
regulating NFAT signaling, we wanted to design a fluorescent protein fusion that could be used 
to monitor the translocation of NFATc2 in cells in real time. mApple seemed to be a fluorescent  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Figure 2.1: FRET sensors detect cytosolic 
calcium. A) MDA-MB-231 cells with a 
genetically encoded calcium sensor were 
treated with ionomycin and EGTA in a calcium-
free buffer (black arrow), causing release of 
calcium from the ER. After a buffer exchange, 
cells treated with ionomycin in a calcium rich 
buffer experienced an immediate and sustained 
increase in cytosolic calcium (white arrow).  
B and C) MDA-MB-231 cells with a genetically 
encoded calcium sensor were imaged over 
night after treatment with B[a]P or cadmium. 
The mean represents the average of the 
normalized FRET ratios of 5 cells in one field of 
view.
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Figure 2.2: MDA-MB-231 cells experience Ca2+ oscillations. A) The normalized FRET ratios of 
five cells within one field of view. After treatment with cadmium, three cells experienced 
oscillations in cytosolic calcium with a period of approximately 4.5 minutes. B) The normalized 
FRET ratios of a single cell after cadmium treatment.
protein ideally suited to the task because of its monomeric character and photostability, as well as 
an excitation range outside that of CFP and YFP53. Fusing mApple to NFATc2 would allow us to 
examine NFAT translocation as a function of both cytosolic calcium and time, as cells are treated 
with cadmium or other environmental carcinogens. 
mApple was cloned onto the amino terminus of NFATc2, and then assayed for activity to test 
whether mApple-NFATc2 could still activate transcription at the IL-2 promoter. We chose to use 
the IL-2 reporter to test activity because NFATc2 is known to act synergistically with cJun to 
induce high levels of transcription at this promoter. In addition, recent findings suggest that cJun/
cJun homodimers bind the carboxyl terminus of NFATc2 in a cofactor interaction in order to get 
full activation of the gene54. Thus, using the IL-2 promoter to test the functionality of mApple-
NFATc2 addresses not only DNA binding activity, but also whether fusion perturbs interactions 
with cJun/cJun homodimers. 
We used an IL-2 Luciferase reporter cotransfected into Cos7 cells with either wild-type 
NFATc2 and cJun, or mApple-NFATc2 and cJun. Transfected cells were stimulated with PMA 
and ionomycin, then Luciferase activity was monitored (Figure 2.3). The Luciferase data show a 
three-fold decrease in activity with the mApple-NFATc2 fusion protein compared to the  
wild-type NFATc2. Despite the decrease in efficacy, however, over-expressing mApple-NFATc2 
and cJun together still exhibited synergistic activation compared to either mApple-NFATc2 or 
cJun alone, suggesting that the reporter is still localizing to the promoter and activating 
transcription to some degree. 
We next asked whether translocation of mApple-NFATc2 into the nucleus might be the 
limiting factor in IL-2 activation (Figure 2.4A). Cells were stimulated with PMA and ionomycin 
for 7 hours, just as in the Luciferase assay. Prior to stimulation, cell nuclei were devoid of 
mApple signal. After stimulation for 7 hours, it appeared that some signal had migrated to the 
nucleus; however, the amount of nuclear NFATc2 was much lower than expected. The addition 
of 30mM lithium acetate, which inhibits the kinases that promote NFAT export, showed a much 
stronger nuclear presence of mApple-NFATc2, although the pattern of fluorescence appeared 
much more punctate than cells not treated with lithium acetate (Figure 2.4B). These experiments 
suggest that mApple-NFATc2 does enter the nucleus upon stimulation, but perhaps it is exported  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Figure 2.3: mApple-NFATc2 is transcriptionally active. Cos7 cells were cotransfected with 
plasmids coding for IL-2-Luciferase and Renilla-null. Relative Luciferase activity was 
determined by dividing the Firefly Luciferase activity by the Renilla Luciferase activity. The 
data were normalized to the average activity in cells not over expressing either cJun or 
NFATc2. Data represent the average of three transfections and error bars represent one 
standard deviation.
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Figure 2.4: mApple-NFATc2 localizes to the nucleus. A) Cos7 cells transfected with mApple-
NFATc2 were fixed and stained before (-) or after (+) 7 hours of stimulation with PMA and 
ionomycin. B) Cos7 cells transfected with mApple-NFATc2 were treated with Lithium Acetate, 
then fixed and stained before (-) or after (+) 7 hours of stimulation with PMA and ionomycin. 
DAPI staining indicates the nucleus, scale bars are 100µm.
A)
B)
more quickly than wild-type NFATc2, leading to a decrease in its transcriptional activity. We are 
currently testing this construct by live cell imaging in MDA-MB-231 cells to try to evaluate how 
NFATc2 responds to stimulation. 
Cadmium activates Cox2 expression in MDA-MB-231 cells 
We also monitored the ability of cadmium to stimulate expression from reporter genes that 
are NFAT responsive, reasoning that activation of these genes would require NFAT translocation 
to the nucleus. We chose to look at expression levels of IL-2 and Cox2 using luciferase reporters. 
IL-2 and Cox2 were chosen specifically because both promoters contain NFAT and AP-1 binding 
sites that are crucial for gene expression54, 55. 
MDA-MB-231 cells transiently transfected with plasmids encoding either IL-2-Luc or  
Cox2-Luc were treated with either 3µM B[a]P or 1µM CdCl2 for between 2 and 20 hours. Figure 
2.5 shows the normalized Firefly luciferase values. While both IL-2 and Cox2 showed slight 
increases upon cadmium exposure, the largest increase in expression was only approximately 
40% greater than the untreated control. Exposure to B[a]P showed even less effect on the 
luciferase values with the maximum Cox2 increase only 25%, and no significant IL-2 induction 
at any time point. 
Cadmium activates genes associated with NFATc2 and cJun 
We wanted to also assess endogenous mRNA expression to better characterize the 
transcriptional programs that B[a]P and cadmium are initiating. To accomplish this, we treated 
MDA-MB-231 cells with 3µM B[a]P or 1µM CdCl2, and for comparison, 1µM ionomycin and 
20ng/mL PMA, which robustly activate the NFAT and cJun signaling cascades respectively. 
After 6 hours, the whole cell RNA was extracted with TRIzol (Invitrogen), and a cDNA library 
was constructed. Gene-specific primers were then added into a semi-quantitative PCR reaction. 
The gene products of Cox2, ENPP2, and TGF-β have all been shown to have a role in 
tumorigenesis or invasion41, 56-58, and are driven in part by the activation of cJun, NFATc2, or 
both. We additionally tested the IL-8 gene as it responds to cJun and NFATc2 stimulation49, and 
HSP40 because of its previously established role in the response to cadmium exposure57. 
Duplicates of each condition were not as consistent as we had hoped. However, as we 
expected, cells stimulated with ionomycin more robustly transcribe Cox2, ENPP2, IL-8, HSP40  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Figure 2.5: Gene reporters in MDA-MB-231 cells. MDA-MB-231 cells were cotransfected with 
plasmids encoding either Cox2-Luc and Renilla-null, or IL-2-Luc and Renilla-null. Cells were 
treated with B[a]P or cadmium for 2, 4, 6, 13, or 20 hours. The values represent the luciferase 
values normalized to the untreated sample. Data represent the average of two samples, and 
the error bars are the range.
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and TGF-β (Figure 2.6). Cells that have been treated with cadmium experience levels of 
activation similar to inonmycin treatment for Cox2, ENPP2, IL-8 genes, and a stronger induction 
of HSP40 and TGF-β. In contrast with cadmium, B[a]P does not induce ENPP2, and appears to 
repress IL-8 expression (Figure 2.6). In either case, the lack of consistency between wells 
suggests that the experiments should be repeated, and perhaps a more quantitative method such 
as q-PCR employed. 
While these genes only represent a handful of all the potential genes we could possibly 
examine, they are sufficient to begin to compare the transcriptional effects of B[a]P and 
cadmium, and whether they activate genes previously published to be responsive to NFAT. Based 
on these data, it appears that cadmium is the more likely of the two carcinogens to activate cJun 
or NFAT-mediated transcription. B[a]P clearly induces stress on the cells, as evidenced by the 
induction of HSP40, but there is no evidence currently that it activates either cJun or NFATc2.  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Figure 2.6: MDA-MB-231 cells express NFATc2 and AP-1 inducible genes. Cells were treated 
in duplicate with B[a]P, CdCl2, ionomycin, or ionomycin and PMA for 6 hours and the whole 
cell RNA extracted. A cDNA copy was generated using a reverse transcriptase and random 
hexamers, and then gene products amplified off the cDNA using gene-specific primers. 
GAPDH -RT samples were treated exactly the same as the other samples with the exception 
of the exclusion of the reverse transcriptase.
Discussion 
Cadmium-induced calcium oscillations may influence NFATc2-controlled genes 
Both polycyclic aromatic hydrocarbons and heavy metals such as cadmium have been shown 
to be carcinogenic compounds, but the mechanisms by which these compounds promote 
tumorigenesis is still unclear. Given the well established roles that both cJun and NFAT 
transcriptional activators play in certain cancers, we wondered if either of these compounds 
would promote either NFAT or cJun activity. In order to probe this question, we first used a 
genetically encoded calcium sensor to examine how exposure to these compounds affected levels 
of calcium in the cytosol of a mammary gland adenocarcinoma. 
Contrary to previously published results–which used small molecule calcium reporters–we 
did not see any increase in cytosolic calcium levels in this cell line over similar time periods. In 
order to address whether these discrepancies are due to experimental methodology, or whether 
the lack of calcium increase is cell line-specific, one would need to perform both calcium sensing 
methods in parallel. 
We were, however, optimistic about seeing calcium oscillations upon cadmium exposure. 
The ubiquitous nature of calcium as a second messenger in cells has recently led researchers to 
question whether the concentration of calcium in the cytosol alone is enough to specifically 
stimulate a cellular response. Experiments have demonstrated that calcium oscillations contribute 
to the specificity of signal transduction, such that different frequency oscillations activate 
different signal cascades34,59. For example, T cells exposed to either constant or oscillating 
calcium concentrations were shown to have a much more robust and selective activation of 
NFAT under the oscillatory conditions than under conditions of constant calcium. We believe that 
a similar mechanism of activation may be occurring in these breast cancer epithelial cells, which 
may help to explain the induction of NFAT responsive genes without the expected steady-state 
increase in cytosolic calcium. 
The induction of genes upon cadmium treatment that are regulated by NFATc2, like Cox2 
and TGF-β, provides evidence of that. Thus, changes in the transcriptional program in  
cadmium-treated cells may be mediated by NFAT activation, and are perhaps also responsive to 
AP-1 inducible elements. Several of the induced genes have documented roles in carginogenesis, 
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supporting the model that NFAT, and potentially cJun, activation could be a key player in this 
process. To fully understand how cadmium works as a carcinogen by changing transcriptional 
programs, a more thorough examination is needed through ChIP-seq of NFAT, combined with 
RNA-seq or Pol II ChIP-seq to assess changes in transcription. Only then can we unravel the role  
that cadmium is playing in NFAT-mediated transcriptional changes. Still, the above results leave 
us confident that we will find NFAT as a key player in mediating this cellular response. 
!
Materials and Methods 
Chemicals and reagents 
Cadmium chloride (Sigma Aldrich) was dissolved in ultra-pure water to a stock concentration 
of 1 M and stored at -20°C. Benzo[a]pyrene (Sigma Aldrich) was dissolved in tissue culture 
grade DMSO to a stock concentration of 50 mM and stored at -20 °C for up to one month. 
Cell culture 
Human mammary adenocarcinoma cells (MDA-MB-231) were cultured in Libovitz’s L-15 
medium supplemented with 10% (v/v) fetal bovine serum, 2 mM L-glutamine, 100 U/mL 
penicillin and 100 µg/mL streptomycin. Cells were maintained at 37 °C and 0% CO2 in a humid 
incubator; they were trypsinized with 0.25% trypsin and subcultured roughly every four days. 
Genetically-encoded reporters were transfected using TransIT-BrCa (Mirus Bio) or 
electroporated using the Neon transfection system (Invitrogen) according to the manufacturer’s 
instructions. Cells were treated with CdCl2 by exchanging medium with fresh medium 
containing 1 µM CdCl2. Similarly, cells were treated with B[a]P or DMSO by exchanging 
medium with fresh L-15 medium containing 3 µM B[a]P. In all cases, the amount of DMSO in 
the medium never exceeded 0.3% (v/v). Live cell imaging was done at 37 °C and 80% humidity 
on a Nikon TE-2000 Widefield microscope (Nikon). 
Cercopithecus aethiops kidney cells (Cos7) were cultured in DMEM supplemented with 10% 
(v/v) fetal bovine serum, 2 mM L-glutamine, 100 U/mL penicillin and 100 µg/mL streptomycin. 
Cells were trypsinized with 0.25% trypsin, subcultured roughly every two days, and maintained 
at 37°C and 5% CO2 in a humid incubator. Genetically encoded reporters were transfected using 
TransIT-2020 (Mirus Bio) according to the manufacturer’s instructions. 
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Plasmid construction 
Plasmid HA-NFATc2 (previously described60) was amplified with primers containing XhoI 
and EcoRI restriction sites, and then digested with those restriction enzymes. Plasmid pcDNA 
3.1(-) (Invitrogen) was similarly digested, and treated with calf intestinal phosphatase (CIP). The 
vector and insert were then combined and ligated. mApple was amplified from pcDNA 3.1(+)-
mApple-NLS (A generous gift from Amy Palmer, Boulder, CO) with primers containing a Kozak 
sequence, and containing XbaI and XhoI restriction sites, then digested accordingly. pcDNA 
3.1(-)-HA-NFATc2 was digested with XbaI and XhoI, followed by CIP treatment. The vector and 
insert were ligated before transformation. All constructs were verified by sequencing. 
Luciferase assays 
250 ng of each protein expression vector, or blank vector, were transfected into Cos7 cells at 
60% confluence in a 12-well plate using TransIT-2020 (Mirus Bio) as per the manufacturer’s 
instructions. 20 hours post-transfection, cells were stimulated with 20 ng/mL PMA and 1 µM 
ionomycin for 7 hours. After 7 hours, cells were harvested in 200 µL 1x Passive Lysis Buffer 
(Promega) for 15 minutes at room temperature. Firefly and Renilla luciferase values were 
determined using the Dual-Luciferase Kit (Promega), and the Firefly values normalized to the 
Renilla values in each well. 
mRNA extraction 
MDA-MB-231 cells at 70% confluence were treated for 6 to 12 hours with CdCl2, B[a]P, 
PMA and Ionomycin, or DMSO. Post treatment, cells were scraped from the plate and spun at 
1100x g for 5 minutes. Supernatant was discarded, and the cells were suspended in 200 µL 
TRIzol (Life Technologies) followed by incubation for 5 minutes. 40 µL of chloroform were 
added and, after 15 seconds of gentle agitation, the solution was centrifuged at 16,000x g for 15 
minutes. The aqueous phase was removed and the RNA was precipitated with 100 µL 
isoporpanol. The collected RNA was pelleted, and washed with 75% ethanol before suspension 
in 1x RQ-1 DNase buffer (Promega). Samples were treated with 1 unit of RQ-1 DNase 
(Promega) for 20 minutes at 37 °C, followed by the addition of 1 µL DNase stop solution and a 
10 minute incubation at 65 °C. cDNA was synthesized from the extracted RNA using 1 unit of 
Multiscribe RT, 10 µM random hexamer primers, and 2 mM dNTPs in 1x RT buffer (Promega). 
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Samples were incubated at 25 °C for 5 minutes, then at 37 °C for 1 hour before ramping up to 
65 °C to inactivate the Multiscribe. Individual mRNA products were detected using custom 
primers in 30-34 cycles of PCR. PCR products were resolved on a 1.8% agarose gel and detected 
using fluorescence scanning (Typhoon).  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Chapter 3: Capturing transient coactivator interactions at the gene promoter 
Introduction 
The combinatorial control over gene expression exhibited by transcription factors presents a 
particularly difficult problem for trying to tease apart how any one gene is regulated. The 
problem is complicated by the fact that transcription factors can function either by binding 
elements on the DNA or through protein-protein interactions16. At present, methods for 
investigating these transcription factors in cells are limited to chromatin immunoprecipitation 
(ChIP) and its derivatives, or co-immunoprecipitation (CoIP) and its derivatives. The former can 
yield substantial information about the sites at which a protein of interest in bound on the 
genome, particularly when combined with next generation sequencing technology. Its scope is 
limited, however, in that the investigator must know the identity of their protein of interest ahead 
of time. In addition, the ChIP signal decreases if a promoter-associated protein is not directly 
bound to DNA. CoIP, on the other hand, identifies protein-protein interactions but requires these 
interactions to be very stable so as to withstand stringent wash conditions. Moreover, CoIPs are 
usually performed from soluble extracts that exclude factors stably associated with chromatin. 
We wanted to develop a technique that could help bridge the gap between these two established 
techniques. 
Recently, Dr. Alice Ting and her colleagues reported work on an enzyme that they used for 
spatially restricted proteomic mapping in mitochondria61. They showed that APEX, an enzyme 
engineered from soybean ascorbate peroxidase (APX), has the ability to utilize hydrogen 
peroxide to generate aromatic radical species62. When given a substrate consisting of biotin 
conjugated to a phenol group, APEX generates a reactive phenoxyl radical with a half-life of 
approximately 1 millisecond. The reactivity of the phenoxyl radical is such that it can covalently 
interact with the exposed aromatic residues of proteins within a tight radius of where the radical 
is created (Figure 3.1). The promiscuous labeling of nearby proteins with a covalent biotin tag 
allows researchers to use simple straptavidin enrichment, in tandem with mass spectrometry, to 
identify the labeled species. The Ting group showed that by genetically targeting APEX to the 
mitochondria, they could achieve labeling of upwards of 96% of the known mitochondrial 
proteome61. 
-   -27
The second generation of APEX, APEX2, was designed to be more versatile by having less 
of a dependance on heme incorporation to achieve a functional protein. Using this improved 
enzyme, Dr. Ting and colleagues have shown that APEX2 can be used to identify the proteome 
of systems that are not enclosed by a membrane (unpublished data). The fast labeling time of the 
enzyme coupled with the relatively nontoxic substrate seem to make APEX2 an ideal candidate 
for identifying proteins associated with specific transcription factors that might evade detection 
through ChIP or CoIP.  We hypothesized that a genetically encoded APEX2 fusion to the 
transcription factor NFATc2 would allow us to identify protein partners of NFATc2 that mediate 
its function as a transcriptional activator.  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Figure 3.1: The structure and labeling scheme for APEX2. A) A crystal structure of soybean 
ascorbate peroxidase with the heme incorporated into the active site. B) A structure of the 
biotin-phenol compound for covalent tagging (X=H). C) A general schematic for APEX labeling. 
APEX accepts aromatic substrates such as the structure shown in (B). This reactive radical 
can covalently interact with other exposed aromatic residues. The half-life of the phenoxyl 
radical is short enough that only proteins in close proximity to APEX will be biotinylated, and 
can then be enriched using streptavidin. 
Results 
NFATc2 tolerates fusion to its N- but not C-terminal region 
Our first aim was to make a transcription factor fusion to APEX2 that remains 
transcriptionally active. We fused APEX2 to either the amino or carboxyl termini of NFATc2, 
separated from the protein by the Human influenza hemagglutinin (HA) epitope tag (see 
schematics in Figure 3.2). In order to test whether the APEX2 fusions to NFATc2 were 
transcriptionally active, we utilized the IL-2-Luciferase reporter because, when co-transfected 
with cJun, it provides a read-out not only on NFAT’s ability to bind DNA, but also its ability to 
interact with other protein factors to mediate high levels of transcription54. 
As shown in Figure 3.2, the normalized Luciferase data show that fusion of APEX2 to the  
C-terminus of NFATc2 significantly reduced the transcriptional activity of NFATc2. By contrast, 
transcriptional activation by the amino-terminal fusion was only minimally impaired.  Moreover, 
the level of activation with cJun and APEX2-NFAT was greater than the additive activation of 
APEX2-NFATc2 and cJun individually, suggesting that the APEX2-NFATc2 is still able not only 
to bind DNA, but also to interact with cJun in mediating a synergistic activation of IL-2. We 
chose to use APEX2-HA-NFATc2 for further experimentation to test this as a tool for 
promiscuous labeling of nuclear proteins in close proximity to NFATc2. 
APEX2-NFATc2 labels nuclear protein upon stimulation 
To test whether the labeling reaction would be contained to the nucleus, we transfected 
MDA-MB-231 cells with APEX2-NFATc2. After 20 hours, cells were stimulated with ionomycin 
and PMA to localize NFATc2 to the nucleus, then labeled 4-7 hours later. The cells were then 
fixed and stained with DAPI and streptavidin conjugated with Alexafluor555; the later would 
detect biotinylated protein. Control experiments showed the labeling reaction required all three 
components of the labeling system: biotin-phenol, H2O2, and APEX2. Stimulation with PMA and 
ionomycin for seven hours was sufficient to ensure that the majority of biotinylation occurred in 
the nucleus, while unstimulated cells had almost no nuclear staining (Figure 3.3). The localized 
staining pattern of the neutravidin555 within the nucleus made us confident that the reactivity of 
the phenol radical with APEX2-NFATc2 is highly specific, and is perhaps detecting where 
APEX2-NFATc2 is localized to euchromatin.  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Figure 3.2: Fusion to the N-terminus of NFATc2 allows the protein to remain transcriptionally 
active. Schematics of the C- and N-terminal fusions to NFATc2 are shown. Cos7 cells were 
cotransfected with plasmids coding for IL-2-Luciferase and Renilla-null. Relative Luciferase 
activity was determined by dividing the Firefly Luciferase activity by the Renilla Luciferase 
activity. The data were normalized to the average activity in cells not over expressing either 
cJun or NFATc2. Data represent the average of three transfections and error bars represent 
one standard deviation.
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Figure 3.3: APEX2-NFATc2 labels nuclear proteins after stimulation. MDA-MB-231 cells 
transiently transfected with APEX2-NFATc2 were stimulated with PMA and ionomycin for 
between 0 and 7 hours, then labeled with biotin-phenol and fixed. Labeled cells were stained 
with DAPI to mark the nucleus, and with Streptavidin-555 to detect biotinylated proteins.
To test whether NFATc2-specific biotinylated nuclear proteins could be detected from a 
cellular lysate, cells were transfected with APEX2-NFATc2 or with APEX2-NLS, which contains 
a nuclear import signal that keeps the protein constitutively in the nucleus. After 20 hours, cells 
were stimulated with PMA and ionomycin, and APEX labeling was performed seven hours later. 
After labeling, cells were pelleted and separate nuclear and cytosolic extracts were prepared. 
Biotinylated proteins in the extracts were detected by Western blotting against biotin. As Figure 
3.4A and B show, nuclear fractions of unstimulated cells have a much weaker label intensity 
across the lane. In cells that were stimulated, their nuclear fractions were highly more enriched 
for the biotin label, though the difference between those treated with lithium acetate before 
stimulation and cells that were just stimulated is small, suggesting that the lithium acetate is not 
required for nuclear labeling. The APEX2-NLS positive control shows the strongest biotin 
signal, which was expected given the localization pattern of NFAT that we observed when using 
mApple-NFATc2. 
Streptavidin enrichment pulls down protein interacting partners 
An important test to ensure that the APEX2 probe is functioning as we expected is to look for 
labeling of proteins known to interact with NFATc2. To do this, we transfected APEX-NFATc2 or 
APEX-NLS into MDA-MB-231 cells, and incubated for 20 hours. Cells were then stimulated 
with PMA and ionomycin for seven hours before labeling. After labeling, the nuclei were 
isolated and the nuclear extracts were incubated with neutravidin beads. Simultaneous  
immunoblots of the enriched nuclear extract against NFATc2 and cJun show that both proteins 
were labeled by APEX2. Additionally, there was a significant amount of self-labeling of APEX2-
NFATc2, which is an important positive control (Figure 3.4 C and D). While the low abundance 
of either protein makes quantitative analysis unreliable, these data give us confidence that we can 
continue to work toward a quantitative assay.  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Figure 3.4: APEX labeling tags nuclear proteins. MDA-MB-231 cells were transiently 
transfected with APEX2-NFATc2 or APEX2-NLS, induced for 7 hours in the presence or 
absence of lithium acetate, and the cells labeled. Nuclear and cytoplasmic fractions were 
separated and the labeled proteins visualized by ponceau stain (A) and immunoblotting 
against biotin (B). Stimulated cells were labeled, and the nuclear and cytoplasmic fractions 
enriched over neutravidin beads. Staining by ponceau shows more protein captured in the 
APEX-NLS samples (C). Immunobloting against cJun and NFATc2 simultaneously show that 
APEX2-NFATc2 labels itself (white arrow), as well as labels cJun (black arrow) (D).
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Discussion 
Understanding a process as complex as the regulation of gene expression in mammals 
requires a large arsenal of tools. Techniques such as ChIP and its new age derivatives can 
generate a great amount of data about the genomic occupancy of any DNA binding protein, but it 
requires a knowledge of what protein to look for and the limits of antibody detection can make it 
hard to distinguish between specific isoforms or post translational modifications. CoIP, when 
coupled with mass spectrometry, does not need fore-knowledge of which proteins might interact 
with the immunoprecipitated protein, but it requires protein interactions that can stand up to 
numerous washes during the extraction process. 
We wanted to see if APEX could be a tool to fill in the gaps left by these two techniques. By 
fusing APEX to a transcription factor, we showed that we can obtain stable labeling of nuclear 
proteins which interact in proximity to that transcription factor (Figure 3.3). The ability to detect 
known interacting partners, like cJun, out of isolated nuclei suggests that the APEX2 labeling 
may be restricted enough to differentially detect proteins associated with NFATc2. Looking 
forward, the APEX-NLS construct could be used as a means of background subtraction such that 
comparing an LC-MS/MS run of the streptavidin enriched nuclear extracts from APEX-NLS and 
APEX-NFATc2 might yield a list of highly enriched proteins with specificity for interacting with 
NFATc2. This technique, then, is not limited by the binding kinetics of the activators and 
coactivators which associate with a promoter and a network of other proteins, but instead is 
limited only by the throughput of the mass spectrometer and the scientist’s ability to 
subsequently test each of these potential interactions. 
We showed that NFATc2 can remain transcriptionally active even when fused to a large 
protein. If one were to repeat this process with other transcription factors (for example cJun and 
NF-𝜅B), and determine their nearby protein interactions in the same way, one could use the 
intersections from their LC-MS/MS data to construct a more extensive picture of the protein 
species interacting with any given transcription factor. Combined with other data such as  
ChIP-seq or CoIP, we have the potential to greatly expand our understanding of mechanisms that 
regulate the combinatorial control of transcription. 
!
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Materials and Methods 
Cell culture 
Human mammary adenocarcinoma cells (MDA-MB-231) were cultured in Libovitz’s L-15 
medium supplemented with 10% (v/v) fetal bovine serum, 2 mM L-glutamine, 100 U/mL 
penicillin and 100 µg/mL streptomycin. Cells were trypsinized with 0.25% trypsin and 
subcultured roughly every four days, and maintained at 37 °C and 0% CO2 in a humid incubator. 
Genetically encoded reporters were transfected using TransIT-BrCa (Mirus Bio) or 
electroporated using the Neon transfection system (Invitrogen) according to the manufacturer’s 
instructions. 
Cercopithecus aethiops kidney cells (Cos7) were cultured in DMEM supplemented with 10% 
(v/v) fetal bovine serum, 2 mM L-glutamine, 100 U/mL penicillin and 100 µg/mL streptomycin. 
Cells were trypsinized with 0.25% trypsin and subcultured roughly every two days, and 
maintained at 37 °C and 5% CO2 in a humid incubator. Genetically encoded reporters were 
transfected using TransIT-2020 (Mirus Bio) according to the manufacturer’s instructions. 
Plasmid construction 
The construction of pcDNA 3.1(-) HA-NFATc2 is described above. To make  
APEX2-HA-NFATc2, the APEX2 insert from pcDNA 3.1(+) APEX2-NLS (a generous gift from 
Alice Y. Ting, Cambridge, MA) was amplified using primers containing XbaI and XhoI 
restriction sites. pcDNA 3.1(-)-HA-NFATc2 was digested with XbaI and XhoI, followed by CIP 
treatment. The vector and insert were ligated before transformation. NFATc2-HA-APEX2 was 
constructed by amplifying APEX2 with NotI and EcoRI restriction sites, and NFATc2 with XbaI 
and XhoI restriction sites. The two inserts were sequentially ligated into the digested  
APEX2-HA-NFATc2 plasmid. All constructs were verified by sequencing. 
Biotin-phenol synthesis 
Synthesis of the biotin-phenol compound was performed by Will Hartwig (Boulder, CO), and 
has been described63. The compound was purified through several rounds of azeotrope formation 
by pyrimidine/toluene fractional distillation. The distillate was then loaded onto a column and 
the resulting crude dissolved in methanol and removed under vacuum with standard dry silica 
gel. The compound was then dry loaded and purified once more through flash chromatography in 
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9:1 chloroform:methanol and crystalized. The material was washed with chloroform and dried 
under vacuum to yield a pure powder. The biotin-phenol was dissolved in tissue culture grade 
DMSO to a concentration of 500 mM, aliquoted and stored at -80 °C. 
APEX2 labeling reaction 
Cells transfected with the APEX2-NLS or APEX2-HA-NFATc2 plasmids were grown for 20 
hours. 30 minutes prior to labeling, cell medium was exchanged with warm PBS containing 
500 µM biotin-phenol. To label, 1 mM H2O2 was added to the cells, and labeling was allowed to 
proceed for 1 minute. After 1 minute, a quencher solution (10 mM sodium azide, 10 mM sodium 
ascorbate, 5 mM 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox)  
(Sigma Aldrich) was added and allowed to incubate on ice for one minute. At this point, cells 
were either fixed in a fixative (10 mM sodium azide, 10 mM sodium ascorbate, 5 mM Trolox, 
4% paraformaldehyde), or collected for protein extraction. 
Immunostaining 
Cells to be immunostained were fixed in 4% paraformaldehyde for 15 minutes at room 
temperature. After 15 minutes, the fixative was removed and the cells washed 3 times in PBS. To 
permeabilize, an appropriate amount of -20 °C methanol was added to the cells, and the plate 
incubated for 5 minutes at -20 °C. The methanol was removed and the cells thoroughly washed 
with PBS before blocking for 1 hour at room temperature using blocking buffer (3% bovine 
serum albumin or 1% casein in PBS). To stain against biotinylated protein, AlexaFluor555-
conjugated streptavidin was added to blocking buffer to a final concentration of 500 ng/mL, and 
added to the cells for 30-60 minutes. After incubation, the cells were washed three times with 
PBS+ 0.1% Tween20, then stained with a 300 nM solution of DAPI (Life Technologies) in  
PBS+ 0.1% Tween20. Finally the cells were washed another three times with PBS+ 0.1% 
Tween20, followed by two washed in PBS. Cells were imaged using an EVOS FL Cell Imaging 
System (Life Technologies). 
Protein extraction and streptavidin enrichment 
Labeled cells were scraped from the bottom of the plate, then transferred to 1.5 ml eppendorf 
tubes and centrifuged at 1100x g for 5 minutes. The supernatant was removed, and the cells 
suspended in 200 µL NROQ buffer (10 mM Tris pH 7.9, 10 mM NaCl, 4 mM MgCl2, 10 mM 
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sodium azide, 10 mM sodium ascorbate, 5 mM Trolox, 1 mM PMSF, 1x Protease Inhibitor 
Cocktail (Roche)) with 0.05% NP-40. Cells were allowed to lyse gently on ice for 10 minutes, 
then spun at 1100x g for 5 minutes. The supernatant was removed, and the nuclei washed once in 
100 µL NROQ with 0.05%. After washing, the isolated nuclei were suspended in NROQ with 
0.15% NP-40 and vortexed in pulses for 15 seconds, then incubated on ice for another 10 
minutes. 
For neutravidin enrichment, 75 µL of 50/50 bead slurry per reaction was centrifuged at  
1100x g for 5 minutes. The beads were suspended in NROQ buffer and allowed to equilibrate for 
5 minutes, before centrifugation at 1100x g. After 3 rounds of washes, the supernatant was 
removed from the equilibrated beads, and cytosolic or nuclear fractions loaded onto them. 
Binding was allowed to proceed for 1 hour while nutating, then the beads were spun at 1100x g 
and the supernatant removed. To remove nonspecific binders, beads were suspended in 250 µL 
NROQ and allowed to nutate for 30 minutes before centrifugation. After the supernatant was 
removed, beads were suspended in 50 µL protein loading buffer (120 mM Tris HCl pH 6.8,  
4% SDS, 0.02% bromophenol blue, 20% glycerol) and incubated for 3 minutes at 95 °C, 
vortexing occasionally. Samples were resolved with SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE), and visualized via silver stain, coomassie stain, or immunoblotting. 
Luciferase assays 
250 ng of each protein expression vector, or blank vector, were transfected into Cos7 cells at 
60% confluence in a 12-well plate using TransIT-2020 (Mirus Bio) as per the manufacturers 
instructions. 20 hours post transfection, cells were stimulated with 20 ng/mL PMA and  
1 µM ionomycin for 7 hours. After 7 hours, cells were harvested in 200 µL 1x Passive Lysis 
Buffer (Promega) for 15 minutes at room temperature. Firefly and Renilla luciferase values were 
determined using the Dual-Luciferase Kit (Promega), and the Firefly values normalized to the 
Renilla values in each well.  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Chapter 4: Characterization of an aptamer that selectively binds cJun/cJun homodimers 
Introduction 
The AP-1 family of proteins is a heterogeneous group of transcription factors containing a 
conserved basic leucine zipper (bZip) domain, and which recognize and bind the consensus 
element 5’-TGA(C/G)TCG-3’, also known as the TPA response element27. AP-1 proteins 
dimerize through their bZip domains, and bind DNA to drive dimer-specific transcriptional 
activation28. While the roles of individual AP-1 proteins are generally well understood in 
aggregate, the contributions of specific dimer pairs in regulating distinct transcriptional programs 
remain mostly unclear. 
Recent evidence for functions unique to cJun/cJun homodimers has emerged53, underscoring 
the need to generate methods to study these individual dimers in the cellular context. Current 
methods to address the roles of individual AP-1 proteins, such as the creation of knock-down or 
knock-out cell lines, do not allow dimer specificity to be addressed. cJun knock-down, for 
example, not only removes cJun/cJun homodimers from the cell, but also all other cJun dimer 
combinations. 
To this end, we employed systematic evolution of ligands by exponential enrichment 
(SELEX) to identify a family of single-stranded DNA aptamers which bind cJun/cJun 
homodimers tightly and specifically, with the ultimate goal of using these aptamers in cells. 
SELEX is a technique that takes advantage of the energetically favorable tertiary structures that 
single-stranded oligonucleotides form64. Aptamers were selected from an initial library of 
approximately 1015 oligos 78 nucleotides in length. Each DNA sequence consisted of a 40 
nucleotide randomized region flanked by constant regions on their 3’- and 5’-ends. These 
aptamers were introduced to DNA-bound cJun/cJun homodimers (Figure 4.1). After washing, 
nucleotide sequences that associated with the DNA-bound cJun/cJun were amplified using 
primers against their constant regions. The ssDNA SELEX pool was regenerated by isolating the 
appropriate strand from the double stranded PCR product, and reintroduced to the target under 
more stringent wash conditions. After 6 rounds, including a negative selection in rounds 5 and 6 
against off-target binders, 46 clones were sequenced65. 
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Here, we screened and characterized a number of these aptamers for their ability to bind 
directly to cJun/cJun. We identified an aptamer which binds cJun/cJun homodimers with greater 
than 100-fold specificity over cJun/cFos heterodimers, and used a variety of biochemical 
techniques to better understand the interaction between cJun/cJun and the aptamer.  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Figure 4.1: A schematic of the selection process for identifying an aptamer against cJun/cJun 
homodimers. Purified cJun/cJun was immobilized by binding an AP-1 element. The 
randomized nucleotide library was allowed to fold into energetically favorable conformations, 
then introduced to the purified protein. Six rounds of SELEX were performed, with the last two 
rounds including a negative selection against off-target binders.
Results 
Binding kinetics suggest aptamers have high affinity and selectivity towards cJun/cJun 
homodimers 
All 46 sequences were different but contained over-represented motifs in the 5’ and 3’ ends of 
the randomized region, suggesting similar responses to the selective pressure from SELEX; 
aptamers 16 and 19 were chosen for further study.  Sequence alignments of aptamer-16 and 
aptamer-19 illustrate the common motifs at the 5’ and 3’ ends of their randomized regions 
(Figure 4.2A). Electrophoretic Mobility Shift Assays (EMSAs) with 32P-labeled aptamer-16 and 
aptamer-19 show that both bound cJun/cJun homodimers with low- to sub-nanomolar affinity 
(Kd of 2.6 nM and 0.4 nM, respectively) (Figure 4.2 B-C). As a point of comparison, we also 
measured the affinity of cJun/cJun for its DNA recognition element, using an AP-1 decoy. The 
AP-1 decoy, a single hairpin containing the consensus AP-1 recognition element, bound  
cJun/cJun homodimers with a Kd of 7.6 nM, consistent with previously reported data66 (Figure 
4.2 D). Aptamer-19 showed an order of magnitude tighter binding than the AP-1 decoy, which 
motivated us to select this aptamer for further study. 
In order to address the selectivity of aptamer-19, we wanted to compare the aptamer’s 
affinity for binding cJun/cJun homodimers to that for binding cJun/cFos heterodimers, another 
well-established dimer combination in the AP-1 family which is thought to activate a different 
transcriptional program than cJun/cJun homodimers. In order to do this, we cloned and expressed 
6xHis-cFos in E.coli and purified the recombinant protein using a Nickel-NTA column. Purified 
cJun and cFos were then combined in stoichiometric amounts and dialyzed. EMSAs using radio-
labeled aptamer-19 showed a roughly 200-fold lower affinity for cJun/cFos heterodimers than for 
cJun/cJun homodimers (Figure 4.3 A), despite the fact that cJun/cFos heterodimers have a higher 
affinity for the consensus AP-1 decoy. The low affinity for cJun/cFos heterodimers suggests that 
aptamer-19 has a high degree of specificity for cJun/cJun homodimers. Measurements of the off-
rate for the cJun/cJun-aptamer-19 complex reveals a relatively stable aptamer-protein complex, 
with a half-life of approximately 16 minutes (Figure 4.3 B). Using the value of the dissociation 
rate constant and the Kd we could calculate an observed association constant of 4.1x106 M-1 s-1. 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Apt-16:gggagatcacttacggcacccggagggtcgttac--ccactgtttgttg--gtataaagcctg--ccaaggctcgggacagcg
Apt-19:gggagatcacttacggcacc-gtatagtcgt-acatgaa-cgagtgtgagtgt-t-aagcctttgccaaggctcgggacagcg
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Figure 4.2: Selection yielded aptamers with a higher affinity for cJun/cJun homodimers than 
the consensus DNA binding sequence. A) Alignment of aptamer-16 and aptamer-19 shows 
two conserved motifs in the randomized region (indicated by a grey box). 5’ and 3’ constant 
regions are shown in bold. B-D) Aptamer-19 and aptamer-16 bind cJun/cJun homodimers with 
a higher affinity than a single-stranded DNA hairpin containing the AP-1 consensus binding 
sequence. Aptamer-19 binds cJun/cJun homodimers with sub-nanomolar affinity (Kd=0.4nM), 
whereas aptamer-16 binds and the AP-1 decoy bind slightly less tightly (Kd=2.6nM and 
Kd=7.6nM respectively).
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Figure 4.3: Aptamer-19 selectively and stably binds cJun/cJun. A) Aptamer-19 has a much 
higher affinity for cJun/cJun homodimers than for cJun/cFos heterodimers. EMSAs titrating a 
broad range of protein concentrations into 32P-labeled aptamer-19 were quantitated and 
plotted. Aptamer-19 binds cJun/cJun homodimers with sub-nanomolar affinity (Kd=0.4nM, 
shown in figure 4.2B), whereas it binds cJun/cFos heterodimer approximately 200-fold weaker 
(Kd=85nM). B) The off-rate of aptamer-19 was determined through EMSA by incubating 32P-
labeled aptamer with cJun/cJun homodimers and allowing complexes to form. 1000-fold 
excess unlabeled aptamer was added, and the reaction loaded onto the gel at increasing time 
points. Aptamer-19 has a dissociation rate kd= 7.1x10-4 s-1, and a half-life of ~16 minutes.
S1 Nuclease reveals regions of the aptamer that are single stranded 
The ability of aptamer-19 to bind cJun/cJun with high affinity and specificity compared to 
other AP-1 dimer combinations inspired us to investigate some of the structural features of the 
aptamer. When given the nucleotide sequence of aptamer-19, structure prediction software such 
as Mfold returned a large number of possible secondary structures based on thermodynamic 
considerations67, 68; experimental information would be required to assess the secondary structure 
of the aptamer. 
In order to experimentally probe the secondary structure of aptamer-19, we employed S1 
nuclease, which cleaves specifically at single-stranded regions of DNA. 32P-labeled aptamer-19 
was allowed to fold into its most thermodynamically stable conformation, and then was 
incubated on ice with increasing amounts of S1 nuclease. After resolution of digested products 
on a denaturing gel, 16 nucleotide positions had a signal at least two times greater than the 
undigested lane (Figure 4.4 A). These data were used as constraints in the structure prediction 
programs, which yielded a single most likely candidate for the structure of the aptamer (Figure 
4.5). 
We noticed that the third stem loop of the predicted structure contains a recognition site for 
the restriction endonuclease CviKI-1, a blunt-end endonuclease which recognizes the double-
stranded sequence 5’-RGCY-3’. To test whether our structure prediction aligned with 
experimental evidence, we incubated the folded aptamer with CviKI-1. As the secondary 
structure predicted, CviKI-1 cleaved the aptamer, with the major product being 54 nucleotides 
long, and a minor product which was 67 nucleotides; this latter product is most likely the result 
of an incomplete cleavage event (Figure 4.4 A). Additionally, we made a modified aptamer in 
which eleven nucleotides on the 5’ end and four nucleotides from the 3’ end (both of which were 
predicted to be single-stranded) were removed. This truncated aptamer-19 (12-74) was digested 
with S1 nuclease and CviKI-1 in an identical manner to the full-length aptamer and the 
fragments resolved on a denaturing gel. Aptamer-19 (12-74) showed a pattern of digestion very 
similar to that of the full-length aptamer (Figure 4.4 B). Cleavage with CviKI-1 yielded a major 
product which was 44 nucleotides in length and a minor product 55 nucleotides in length, as the 
secondary structure would predict. The smaller aptamer also allowed better resolution of the  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Figure 4.4: S1 nuclease digestion reveals single-stranded regions of aptamer-19. A) 32P-labeled aptamer-19 
was incubated with the restriction endonuclease CviKI-1, or with increasing amounts of S1 nuclease. The 
resulting fragments were resolved on a denaturing gel. The plot next to the gel represents the pixel intensity 
of lane 5, the dashed line is the cut off used to determine single stranded nucleotides, and position numbers 
refer to the full-length aptamer. Digestion with CviKI-1 yields a 54 nt major product and a 67 nt minor product, 
consistent with our predictions. S1 cleavage of the full-length aptamer reveals four major single-stranded 
regions. B) To achieve better resolution at the 3’ end of the aptamer, aptamer-19 (12-74) was digested 
exactly as before. Consistent with the full length aptamer, when digested with CviKI-1 aptamer-19(12-74) has 
a 44 nt major product and a 55 nt minor product. Additionally, S1-nuclease digestion of aptamer-19(12-74) 
reveals a single-stranded region between nucleotides 47 and 51, corresponding to the unresolved peaks 
towards the top of (A).
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Figure 4.5: Data from S1-nuclease digestion reveals a probable secondary structure of 
aptamer-19. Grey dots indicate single-stranded regions revealed by S1 digestion of the full-
length aptamer, while asterisks denote single-stranded regions in the 12-74 nt truncation. The 
position of the CviKI-1 digestion site is marked by the dashed line. Using these data as 
parameters, we were able to predict a secondary structure. The two conserved motifs between 
aptamer-16 and aptamer-19 are highlighted in grey.
upper bands on the gel, allowing us to detect individual cleavage events by S1 nuclease in the 
47-51 nucleotide region, which supports the secondary structure model. 
DNase I footprinting suggests that aptamer-19 may target unique elements in the activation 
domain of cJun/cJun homodimers 
Given the higher affinity of aptamer-19 for cJun/cJun homodimers, we asked whether this 
interaction was caused by an interaction within the domains unique to cJun/cJun homodimers. In 
order to probe this, we separately expressed the bZip domain of cJun, which is highly conserved 
within AP-1 family proteins. We evaluated the ability of full length cJun/cJun to protect 
aptamer-19 from cleavage by DNase I compared to the bZip region of cJun. DNase I cleaves 
DNA in a non-sequence-specific manner, but given the inherent bulk of the enzyme, it cannot 
access nucleotides which are already associated with protein. This technique, then, allows us to 
determine which regions of the aptamer are actively associated with protein. 
Incubation of aptamer-19 with DNase I revealed seven regions which are cleaved with high 
frequency, most likely owing to either the preference of DNase I for double stranded DNA over 
single-stranded, or the solvent accessibility of certain regions in the aptamer (Figure 4.6.A, B). 
When cJun/cJun homodimers were added to the reaction, cleavage of the aptamer was greatly 
reduced in all but one position on the aptamer, suggesting that multiple regions of the aptamer 
are involved in interactions with the proteins. 
When incubated with cJun-bZip, even at high concentrations, there was very little protection 
due to protein binding. Unfortunately, experiments with the AP-1 decoy and cJun-bZip do not 
show the protection that we would have expected (data not shown), so the lack of protection is 
not conclusive evidence. Still, these data favor a model in which the aptamer binds some unique 
feature on the cJun/cJun homodimer that the bZip dimers alone lack. 
Systematic truncations of aptamer-19 suggest a minimal binding domain required for  
cJun/cJun binding 
Motivated by the idea that minimizing the size of the aptamer to only the regions required for 
tightly binding cJun/cJun would reduce off-target effects when used in cells, we sought to 
identify the minimal binding domain of aptamer-19. With a proposed secondary structure, as well 
as DNase I data in hand, we attempted to identify the minimal region by making systematic  
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truncations from both ends of the aptamer. Six truncations were chosen that could reduce the size 
of the aptamer from 78 nucleotides to 31 nucleotides. As we anticipated, removal of the 5’ 
single-stranded region had a negligible effect on binding affinity, and in fact reduced the 
occurrence of multimer aggregation in electrophoretic mobility shift assays (EMSAs) (Figure 
4.7). Surprisingly, destruction of the first stem loop by removing the first 22 nucleotides from the 
5’ end reduced binding affinity of aptamer-19 by only approximately 10-fold. Any further 
truncation completely obliterated cJun/cJun homodimer binding over the range shown. 
Removal of nucleotides from the 3’ end showed a much higher dependance on the 3’ single-
stranded region. The first four nucleotides did not contribute to binding affinity, but removal of 
the next 8 resulted in a significant decrease in binding affinity. Unsurprisingly, a truncation 
which destroyed the third stem loop completely abolished protein binding. Given these data, we 
chose to use the 12-74 truncation as a possible tool for in vivo experimentation.  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Figure 4.6: A) DNase footprinting of aptamer-19 
reveals a broad range of contacts with cJun/cJun 
homodimers. 32P-labeled aptamer-19 was incubated 
with increasing amounts of either cJun/cJun 
homodimers (lanes 3-6) or with dimers of the basic 
leucine zipper (bZip) domain (lanes 7-10) and 
compared to aptamer-19 with no protein added (Lanes 
2 and 11). Complexes were allowed to form for 20 
minutes, then DNase1 was added for 1 minute. 
Digested fragments were precipitated in ethanol and 
then run on an 11% polyacrylamide gel. B) Plots 
comparing pixel intensity of bands with or without 
protein are shown above. Aptamer-19 is broadly 
protected, even at relatively low amounts of cJun/cJun 
homodimers, whereas it is not protected by the bZip 
domain.
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Figure 4.7: Systematic truncations of aptamer-19 reveal a minimal domain required for high-
affinity binding. Truncations were made from both the 3’ and 5’ ends of aptamer-19. Each 
truncation was 32P-labeled, the incubated with cJun/cJun homodimers for 20 minutes before 
being loaded into an EMSA. These data show that nucleotides out to position 74 are required 
on the 3’ end. The first 12 nucleotides can be removed from the 5’ end with minimal loss of 
binding affinity (Kd= 0.4nM), and binding is still possible with the first 23nt removed, though 
some affinity is lost. 
Discussion 
Aptamer-19 binds cJun/cJun homodimers with surprising affinity 
We have reported here the characterization of an aptamer which binds cJun/cJun homodimers 
selectively and with high affinity. Given the pivotal roles of certain AP-1 proteins in the growth 
and proliferation of multiple forms of cancer, developing a probe which can potentially 
differentiate cJun/cJun from the many possible permutations of dimers that can exist within the 
AP-1 family could have a large impact in understanding exactly what role cJun/cJun plays in the 
cell. 
SELEX is a process which is designed to pull out families of aptamers that have high affinity 
and specificity for a particular factor of interest. Given that the highly basic DNA binding 
domain of cJun/cJun was masked with the canonical AP-1 sequence throughout the selection 
process, we did not expect that the aptamer would be able to succeed in surpassing the binding 
affinity of the native protein to its target sequence. Such a large binding affinity suggests that a 
low concentration of aptamer would be sufficient to bind cJun/cJun homodimers in the cellular 
context. 
Footprinting data underscore the importance of aptamer structure 
The process of SELEX requires constant regions flanking the randomized nucleotide region 
to be able to amplify and identify the desirable aptamers throughout the selection process. Our 
experiments with S1 cleavage and DNase I footprinting, as well as analysis of sequence 
homology between binding aptamers, suggest that tightly binding aptamers contained regions on 
both 5’ and 3’ ends which base pair with regions in the constant region of the full-length aptamer. 
Through truncations of the aptamer, we found that some nucleotides within the constant regions 
were required for tight binding. Indeed, even some nucleotides that were predicted to be single-
stranded were crucial for the function of the aptamer. Without the ability to achieve a high-
resolution crystal structure of aptamer-19, we can only speculate as to its tertiary structure or the 
specific roles of any one of the nucleotides. It is clear, however, that a different choice of 
constant region would have an effect on the sequence and structure of the aptamers that 
succeeded in the selection process. This only serves to highlight the power of the SELEX process 
and underscores its flexibility as a tool for a wide variety of biological problems. 
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Aptamer-19 (12-74) has the potential to be a powerful tool 
Having developed a tool, which we have shown binds cJun/cJun homodimers specifically 
over cJun/cFos, we now look forward to its implementation as a tool in understanding the role of 
cJun/cJun homodimers in regulating gene expression. Some instances of dimer-specific AP-1 
functions have already been elucidated, either using in vitro characterization or carefully targeted 
knock-downs of certain AP-1 proteins. Unfortunately the scope of these findings are relatively 
narrow.  
With the ability to target a specific dimer combination, one can imagine that an entire realm 
of possibilities opens up. RNA-seq or Pol II ChIP-seq, in addition to a cJun ChIP-seq, using cells 
treated with aptamer-19 could reveal the loci on the genome at which cJun/cJun homodimers act 
specifically to regulate the expression of protein-coding messages. Further experimentation and 
modification of the existing aptamers could result in a tool that can specifically target cJun/cJun 
homodimers for export from the nucleus and subsequent degradation. Aptamers specific for other 
AP-1 dimer combinations could be developed. This aptamer and the SELEX approach are both 
valuable tools in understanding the role and scope of cJun/cJun homodimers as AP-1 
transcriptional activators. 
!
Methods and Materials 
Plasmid preparation 
pET-cJun, pET-cJun(c269s), and pET-6xHis-cFos have been described previously60, 65. 
pET-6xHis-cFos(c154s) was constructed using QuickChange site directed mutagenesis in order 
to limit protein aggregation in EMSAs. 
Protein purification 
cJun/cJun homodimers were recombinantly expressed and purified as described previously. 
To make cJun/cFos heterodimers, cultures were co-transformed with pET-6xHis-cFos and 
pSBET and grown in the presence of 100 µg/mL ampicillin and 50 µg/mL kanamycin in Luria-
Bertani broth at 37 °C. When an optical density at 600 nm reached 0.4, cultures were induced 
with 0.5 mM isopropylthio-β-D-galactoside. After 2 hours, cells were harvested and the cell 
pellet resuspended in a buffer containing 20 mM Tris (pH 7.9), 1 mM EDTA, 0.1 M NaCl, 1 mM 
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DTT, 0.2 mM phenylmethylsulfonyl fluoride (PMSF) and sonicated four times for 15 seconds. 
Samples were centrifuged for 30 minutes at 15,000 rpm and 4 °C. The supernatant was 
discarded, and the pellet containing 6xHis-cFos was resuspended in 10 mL of 20 mM Tris (pH 
7.9), 1 mM EDTA, 0.1 M NaCl, 5 mM DTT, 0.2 mM PMSF and sonicated two times for 30 
seconds. The pellet was washed three times by resuspension in 10 mL of 20 mM Tris (pH 7.9),  
1 mM EDTA, 0.1 M NaCl, 5 mM DTT, 0.2 mM PMSF. The pellet from the last wash was 
resuspended in 10 mL of buffer A (20 mM Tris (pH 7.9), 1 mM EDTA, 5 mM DTT, 8 M Urea, 
0.1 M NaCl) containing 20 mM imidazole. Soluble material was loaded onto a Ni-NTA agarose 
column (Qiagen) and washed with 5 column-volumes of buffer A containing 20 mM imidazole, 
followed by 5 column-volumes of buffer A containing 40 mM imidazole. Bound protein was 
eluted from the column using buffer A containing 500 mM imidazole. Purified 6xHis-cFos was 
mixed with an equal molar amount of purified cJun in buffer A, then sequentially dialyzed in 
buffer B (20 mM Tris (pH 7.9), 0.1 mM EDTA, 10% glycerol, 5 mM DTT) containing: (1) 1 M 
urea and 1 M NaCl, (2) 1 M NaCl, then (3) 0.1 M NaCl. Purified and folded cJun/cFos 
homodimers were aliquoted and stored at -80 °C. 
Electrophoretic mobility shift assays 
Recombinantly expressed cJun, cJun-bZip, or cFos was diluted into buffer DB (100 mM 
KCl, 20% glycerol, 40 mM Tris (pH 7.9), 0.1 mM DTT, 120 µg/ml BSA, and 0.12% NP-40). 
32P-Labeled aptamers were diluted into buffer RM (100 mM KCl, 8 mM MgCl2, 40 mM HEPES 
(pH 7.9), 0.1 mM DTT), then heated to 95 °C for 2 minutes before being rapidly cooled in an ice 
bath to favor the most thermodynamically stable conformations. Reactions were assembled in 
20 µL of buffer DB/RM (100 mM KCl, 10% glycerol, 4 mM MgCl2, 20 mM Tris (pH 7.9), 
20 mM HEPES (pH 7.9), 0.1 mM DTT, 60 µg/ml BSA, and 0.06% NP-40) on ice, then the 
complexes were allowed to form by incubation for 20 minutes at room temperature. After 
incubation, 40 ng of poly dI•dC were added to each reaction as a non-specific competitor, and 
the reactions were subjected to electrophoresis through a 4% polyacrylamide gel containing 1x 
TG buffer and 5% glycerol. Gels were run for 60-90 minutes, then transferred to Whatman paper 
and dried. Radioactivity was detected using a phosphorimager screen (Amerisham Biosciences) 
then scanned using a Typhoon scanner. In all cases, DNA concentrations were kept at 50 pM. 
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S1 Nuclease footprinting 
10 fmol of 32P-labeled aptamer-19 were folded in buffer RM (100 mM KCl, 8 mM MgCl2, 40 
mM HEPES (pH 7.9), 0.1 mM DTT) by heating to 95 °C for 2 minutes before rapidly cooling in 
an ice bath. This was then added to 1x S1 Nuclease buffer (Promega), and incubated on ice with 
between 1 and 20 units of S1 Nuclease for 1 minute. The reaction was quenched using stop mix 
(200 mM KCl, 50 mM EDTA, 0.3 mg/mL yRNA, 1% glycogen), then phenol-chloroform 
extracted. The resulting fragments were precipitated in ethanol before resolving on an 11% 
denaturing polyacrylamide gel. Radioactivity was detected using a phosphorimager screen 
(Amerisham Biosciences) then scanned using a Typhoon scanner, and the data were quantitated 
using ImageJ software. 
DNase1 footprinting 
10 fmol of 32P-labeled aptamer-19 were folded in buffer RM (100 mM KCl, 8 mM MgCl2, 40 
mM HEPES (pH 7.9), 0.1 mM DTT) by heating to 95 °C for 2 minutes before rapidly cooling in 
an ice bath. This was added to recombinant purified cJun or cJun-bZip in buffer DB/RM (100 
mM KCl, 10% glycerol, 4 mM MgCl2, 20 mM Tris (pH 7.9), 20 mM HEPES (pH 7.9), 0.1 mM 
DTT, 60 µg/ml BSA, and 0.06% NP-40) in a 20 µL reaction, and the complexes were allowed to 
form for 20 minutes at 30 °C. After 20 minutes, 5 units DNase and 20 µmol CaCl2 were added to 
the reaction and incubated for 1 minute. The reaction was quenched using stop mix (200 mM 
KCl, 50 mM EDTA, 0.3 mg/mL yRNA, 1% glycogen), then phenol-chloroform extracted. The 
resulting fragments were precipitated in ethanol before resolving on an 11% denaturing 
polyacrylamide gel. Radioactivity was detected using a phosphorimager screen (Amerisham 
Biosciences) then scanned using a Typhoon scanner, and the data were quantitated using ImageJ 
software.  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